Earnings Feed
Start Free
Home/Insiders/WELCH WILLIAM J
WW
SEC Insider//CIK 0001237522

WELCH WILLIAM J

CIK 00012375224 companiesSOUTH SAN FRANCISCO, CA
SEC Profile

Transactions

50

Companies

4

Filings

11

CIK

0001237522

Recent Transactions

50 trades
  • Exercise/Conversion
    Cardiff Oncology, Inc.$CRDF

    Restricted Stock Units

    2018-01-30−130,000→ 150,000 total
  • Exercise/Conversion
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2018-01-30+130,000→ 904,655 total
  • Tax Payment
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2018-01-30−62,010→ 842,645 total
  • Award
    Cardiff Oncology, Inc.$CRDF

    Stock Options

    2018-01-23+662,500→ 1,412,500 total
  • Exercise/Conversion
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2018-01-02+50,000→ 800,142 total
  • Tax Payment
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2018-01-02−25,487→ 769,905 total
  • Exercise/Conversion
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2018-01-02+50,000→ 795,392 total
  • Exercise/Conversion
    Cardiff Oncology, Inc.$CRDF

    Restricted Stock Units

    2018-01-02−50,000→ 280,000 total
  • Exercise/Conversion
    Cardiff Oncology, Inc.$CRDF

    Restricted Stock Units

    2018-01-02−50,000→ 280,000 total
  • Tax Payment
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2018-01-02−25,487→ 774,655 total
  • Award
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2017-08-15+745,392→ 745,392 total
  • Award
    Cardiff Oncology, Inc.$CRDF

    Restricted Stock Units

    2017-04-07+130,000→ 330,000 total
  • Award
    Cardiff Oncology, Inc.$CRDF

    Restricted Stock Units

    2017-01-02+200,000→ 200,000 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2016-12-16$2.10/sh+2,500→ 2,500 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2016-12-16$2.09/sh+2,250→ 4,750 total
  • Exercise/Conversion
    SEQUENOM INC

    Restricted Stock Unit

    2015-06-10−5,500→ 258,874 total
  • Exercise/Conversion
    SEQUENOM INC

    Common Stock

    2015-06-10+5,500→ 58,127 total
  • Tax Payment
    SEQUENOM INC

    Common Stock

    2015-06-10$3.34/sh−2,067→ 56,060 total
  • Purchase
    SEQUENOM INC

    Common Stock

    2015-03-10$3.65/sh+10,000→ 52,627 total
  • Award
    SEQUENOM INC

    Restricted Stock Unit

    2015-02-10+180,000→ 277,874 total
  • Award
    SEQUENOM INC

    Incentive Stock Option (right to buy)

    2015-02-10+11,228→ 11,228 total
  • Award
    SEQUENOM INC

    Non-Qualified Stock Option (right to buy)

    2015-02-10+218,772→ 218,772 total
  • Exercise/Conversion
    SEQUENOM INC

    Restricted Stock Unit

    2015-02-10−13,500→ 264,374 total
  • Exercise/Conversion
    SEQUENOM INC

    Common Stock

    2015-02-10+13,500→ 47,701 total
  • Tax Payment
    SEQUENOM INC

    Common Stock

    2015-02-10$3.47/sh−5,074→ 42,627 total
  • Exercise/Conversion
    SEQUENOM INC

    Common Stock

    2014-12-10+10,938→ 36,874 total
  • Exercise/Conversion
    SEQUENOM INC

    Restricted Stock Unit

    2014-12-10−10,938→ 97,874 total
  • Tax Payment
    SEQUENOM INC

    Common Stock

    2014-12-10$3.73/sh−4,111→ 32,763 total
  • Award
    SEQUENOM INC

    Incentive Stock Option (right to buy)

    2014-02-01+31,500→ 31,500 total
  • Award
    SEQUENOM INC

    Restricted Stock Unit

    2014-02-01+54,000→ 86,812 total
  • Award
    SEQUENOM INC

    Non-Qualified Stock Option (right to buy)

    2014-02-01+76,500→ 76,500 total
  • Award
    SEQUENOM INC

    Common Stock

    2013-12-10+10,938→ 25,688 total
  • Tax Payment
    SEQUENOM INC

    Common Stock

    2013-12-10$2.34/sh−4,111→ 21,577 total
  • Disposition to Issuer
    SEQUENOM INC

    Restricted Stock Unit

    2013-12-10−10,938→ 32,812 total
  • Tax Payment
    SEQUENOM INC

    Common Stock

    2013-06-19$4.22/sh−3,320→ 13,215 total
  • Award
    SEQUENOM INC

    Common Stock

    2013-06-19+8,833→ 16,535 total
  • Award
    SEQUENOM INC

    Restricted Stock Unit

    2012-12-10+43,750→ 43,750 total
  • Award
    SEQUENOM INC

    Non-Qualified Stock Option (right to buy)

    2012-12-10+73,264→ 73,264 total
  • Award
    SEQUENOM INC

    Incentive Stock Option (right to buy)

    2012-12-10+14,236→ 14,236 total
  • Award
    SEQUENOM INC

    Common Stock

    2012-02-07+294→ 4,708 total
  • Award
    SEQUENOM INC

    Non-Qualified Stock Option (right to buy)

    2012-02-07+72,033→ 72,033 total
  • Award
    SEQUENOM INC

    Common Stock

    2012-02-07+1,166→ 3,248 total
  • Award
    SEQUENOM INC

    Incentive Stock Option (right to buy)

    2012-02-07+87,967→ 87,967 total
  • Award
    SEQUENOM INC

    Common Stock

    2012-02-07+1,166→ 4,414 total
  • Tax Payment
    SEQUENOM INC

    Common Stock

    2011-07-18$7.46/sh−534→ 924 total
  • Award
    SEQUENOM INC

    Common Stock

    2011-07-18+1,458→ 1,458 total
  • Award
    Monogram Biosciences, Inc.

    Stock Option (Rt to Buy)

    2009-01-16+35,000→ 35,000 total
  • Award
    Monogram Biosciences, Inc.

    Stock Option (Rt to Buy)

    2009-01-16+35,000→ 35,000 total
  • Award
    Monogram Biosciences, Inc.

    Stock Option (Right to Buy)

    2005-08-31+300,000→ 300,000 total
  • Award
    LA JOLLA PHARMACEUTICAL CO

    Stock Option (right to buy)

    2005-05-19$0.43/sh+33,850→ 472,500 total

Companies

4

Recent Filings

11

Address

C/O MONOGRAM BIOSCIENCES, INC. 345 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov